VTYX Ventyx Biosciences, Inc: Forvard narx/daromad multiplikatori
Ventyx Biosciences bio-chiqindilarni yo'q qilish standartlariga qat'iy rioya qiladi, bu esa jarayon barqarorligini ta'minlaydi. Bashorat qilingan P/S baholash ko'rsatkichi bozor optimizmini aks ettiradi, bunda joriy holat ga tengdir. O'sish potentsiali Kron bo'yicha kasallangan bemorlar uchun oral preparatlarning ishlab chiqilishiga asoslangan. Moliyaviy muvaffaqiyat molekulalarni sog'liqni saqlash gigantlariga litsenziyalash orqali kutilmoqda, bu esa ishlab chiqarish xarajatlarisiz yuqori marjalarni ta'minlaydi.
Ventyx Biosciences, Inc (VTYX) kompaniyasining tahliliy kesimlari
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- biznesning balans baholash tafsilotlari:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Umumiy qarzning xususiy kapitalga nisbati Ventyx Biosciences|VTYX - Uzoq muddatli kreditlarning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Ventyx Biosciences|VTYX - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans qiymatiga nisbati Ventyx Biosciences, Inc|VTYX - Kompaniyaning uzoq muddatli qarzdorligi|Kompaniyaning qisqa muddatli majburiyatlari Ventyx Biosciences|Tezkor likvidlik koeffitsiyenti ventyxbio.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
VTYX - Kompaniyaning sof foydasi|Prognoz qilingan kelajakdagi foyda Ventyx Biosciences|VTYX - Biznesning o‘zini qoplash muddati|Kelajakdagi narxning foydaga nisbati Ventyx Bio|VTYX - O‘sish sur’atiga tuzatilgan narx-foyda|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Ventyx Biosciences, Inc|VTYX - Amortizatsiya chegirilmasdan oldingi operatsion daromad|Bir aksiya uchun sof foyda (EPS TTM) Ventyx Biosciences|VTYX - So'nggi 12 oy davomida bir aksiya uchun sof foyda|Choraklik EPS foyda o'sishi ventyxbio.com|VTYX - Bu yil bir aksiya uchun sof foydaning kutilayotgan o'sishi|Keyingi yil uchun foyda o'sishi prognozi Ventyx Biosciences
- tushum va sotuvlar tafsilotlari:
Kompaniyaning dastlabki tahlili:Ventyx Biosciences, Inc. (VTYX)
Ventyx Biosciences (VTYX) barqarorligi yallig'lanish terapiyasi uchun innovatsion oral dori vositalarining ishlab chiqilishiga bog'liq bo'lib, bu kompaniyaning uzoq muddatli daromad potentsialini belgilaydi. Forward P/S koeffitsiyenti joriy bozor kapitalizatsiyasini kutilayotgan sotuvlar bilan bog'lab, bozorning kelajakdagi o'sish uchun premium to'lashga tayyorligini o'lchaydi; shuning uchun, prognozlarga asoslangan forward P/S tahlili likvidlik oqimlari fonida aktivlarning haddan tashqari qimmat baholanishi xavfini aniqlashga yordam beradi.
Ventyx Biosciences raqobatchilari tahlili
Forvard P/S multiplikatori ARGX (argenx)|BioNTech Inc. (BNTX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|ABVX: Forvard narx/daromad multiplikatori|ADMA: Narxning prognoz qilingan daromadga nisbati|PTGX: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati immunovant.com (IMVT)|Narxning prognoz qilingan daromadga nisbati Kiniksa|Kapitalizatsiyaning prognoz qilingan daromadga nisbati GRFS (Grifols SA)|Forvard narx/daromad multiplikatori ADPT (Adaptive Biotechnologies Corp)|Narxning kutilayotgan daromadga nisbati CLDX|Aurinia Pharmaceuticals - Forvard narx/daromad multiplikatori|biocryst.com (BCRX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|VERA: Forvard narx/daromad multiplikatori|DNTH (Dianthus Therapeutics Inc) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|PHVS (Pharvaris Corp) - Forvard narx/daromad multiplikatori|AbCellera Corp - Sotuvga nisbatan forvard narx|TRML (Tourmaline Bio, Inc.) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati PGEN|Forvard P/S multiplikatori PHAR|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Nektar Therapeutics Inc|Narxning prognoz qilingan daromadga nisbati Upstream Bio Corp UPB|Zenas Corp (ZBIO) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|IMNM - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning kutilayotgan sotuvga nisbati gossamerbio.com GOSS|KALV: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Septerna, Inc.|PVLA (Pieris Pharmaceuticals Inc) - Forvard P/S multiplikatori|Savara Pharma (SVRA) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard P/S multiplikatori RIGL|ANAB - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Astria Therapeutics, Inc. ATXS|ENGN: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|RAPT Therapeutics, Inc. - Forvard P/S multiplikatori|Aerovate Therapeutics Inc (JBIO) - Forvard narx/daromad multiplikatori|ACRS: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati kyvernatx.com (KYTX)|Narxning prognoz qilingan daromadga nisbati Tiziana Life Sciences Ltd|Cabaletta Bio Inc. (CABA) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard narx/daromad multiplikatori THTX (Theratechnologies Inc)|Narxning prognoz qilingan daromadga nisbati AVTX (Avalo Therapeutics Inc)|Eledon Pharmaceuticals - Forvard narx/daromad multiplikatori|Narxning kutilayotgan daromadga nisbati AGEN (agenusbio.com)|CLYM: Forvard narx/daromad multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Zura Bio Ltd|ATYR (aTyr) - Forvard narx/daromad multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati ADAG|Narxning prognoz qilingan daromadga nisbati ImageneBio|Shattuck Therapeutics - Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori EQ|CNTB (connectbiopharm.com) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori IMUX (Immunic)|Forvard P/S multiplikatori Atara Biotherapeutics, Inc. ATRA|IFRX - Narxning prognoz qilingan daromadga nisbati|Sotuvga nisbatan forvard narx XFOR (x4pharma.com)|adicetbio.com (ACET) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori Celularity|INMB (INmune Bio Corp) - Forvard P/S multiplikatori|Forvard P/S multiplikatori Barinthus Biotherapeutics Corp|Forvard narx/daromad multiplikatori KZR (Kezar Life Sciences)|SABS (sabbiotherapeutics.com) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori AKTX (Akari Therapeutics Plc)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Enlivex Therapeutics Ltd (ENLV)|QTTB - Narxning prognoz qilingan daromadga nisbati|GeoVax Corp (GOVX) - Forvard narx/daromad multiplikatori|Edesa Biotech, Inc. (EDSA) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori ibioinc.com|Forvard narx/daromad multiplikatori CARM|Forvard P/S multiplikatori XTL Biopharmaceuticals Ltd|Narxning prognoz qilingan daromadga nisbati Bolt Biotherapeutics (BOLT)|hcwbiologics.com - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Forvard P/S multiplikatori APVO (Aptevo Therapeutics Inc.)|AIM ImmunoTech, Inc. (AIM) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|ADTX: Forvard narx/daromad multiplikatori|GRI: Narxning prognoz qilingan daromadga nisbati|XRTX: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Vyome Therapeutics (HIND)|Narxning prognoz qilingan daromadga nisbati Revelation Biosciences|Kapitalizatsiyaning prognoz qilingan daromadga nisbati INDP (indaptusrx.com)|Forvard narx/daromad multiplikatori SCNI (Scinai Immunotherapeutics Ltd.)|Narxning kutilayotgan daromadga nisbati CALI|Affimed N.V. - Forvard narx/daromad multiplikatori|Allakos Inc (ALLK) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|HOOK: Forvard narx/daromad multiplikatori|IGMS (IGM Biosciences, Inc.) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|ITOS (iTeos Therapeutics, Inc.) - Forvard narx/daromad multiplikatori|Ocean Biomedical Inc - Sotuvga nisbatan forvard narx|TCBP (TC BioPharm (Holdings) PLC) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati THRD
